J. Goldman & Co LP

Position in LQDA — Liquidia Corp

CIK 1412741 NEW YORK, NY

Back to LQDA Full portfolio

Position in LQDA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$453,332

-$96,498 QoQ

Shares Held

12,012

-50.3% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LQDA Over Time

Shares Held

Position Value (USD)

Derivatives in LQDA

reported options exposure · as of Mar 31, 2026

CallValue

$3,566,430

CallShares

94,500

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

J. Goldman & Co LP holds $5,272,240 across 4 Drug Manufacturers - Specialty & Generic names. LQDA ranks #3 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DERM	Journey Medical Corp	500,188	$2,345,881
2	PCRX	Pacira BioSciences, Inc.	97,772	$2,209,647
3	LQDA	Liquidia Corp This page	12,012	$453,332
4	CPIX	Cumberland Pharmaceuticals Inc	81,040	$263,380

All Filings in LQDA

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$453,332	12,012	-87.3%	Shares	Sole	2026-05-15
2026-03-31	$3,566,430	94,500	+290.8%	Call	Sole	2026-05-15
2025-09-30	$549,830	24,179	-55.2%	Shares	Sole	2025-11-14
2022-09-30	$293,760	54,000	—	Call	Sole	2022-11-14
No filing history on record for this holder in this stock.